ロード中...
Practical considerations on the use of rituximab in autoimmune neurological disorders
Rituximab (Mabthera, Rituxan) is a chimeric human/murine monoclonal antibody against CD-20 surface antigen expressed on B-cells. Rituximab, by causing B-cell depletion, appears to be effective in several autoimmune disorders; it has been approved for rheumatoid arthritis and is a promising new agent...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3002645/ https://ncbi.nlm.nih.gov/pubmed/21179602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285609356135 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|